Tower Research Capital LLC (Trc) Navidea Biopharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.07 - $0.12 $75 - $129	1,080 Added 13.75%	8,937 $0
Q2 2023 Aug 14, 2023	SELL	$0.08 - $0.29 $4 - $15	-54 Reduced 0.68%	7,857 $0
Q1 2023 May 09, 2023	BUY	$0.24 - $0.34 $2 - $3	11 Added 0.14%	7,911 $2,000
Q4 2022 Feb 10, 2023	SELL	$0.18 - $0.3 $94 - $157	-524 Reduced 6.22%	7,900 $2,000
Q3 2022 Nov 10, 2022	BUY	$0.24 - $0.71 $1,438 - $4,256	5,995 Added 246.81%	8,424 $2,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $1.1 $1,016 - $1,774	-1,613 Reduced 39.91%	2,429 $2,000
Q1 2022 May 12, 2022	SELL	$0.72 - $1.2 $1,127 - $1,879	-1,566 Reduced 27.92%	4,042 $3,000
Q4 2021 Feb 14, 2022	SELL	$1.0 - $1.82 $786 - $1,430	-786 Reduced 12.29%	5,608 $6,000
Q3 2021 Nov 15, 2021	BUY	$1.53 - $1.85 $9,782 - $11,828	6,394 New	6,394 $11,000
Q2 2021 Aug 16, 2021	SELL	$1.55 - $2.15 $1,213 - $1,683	-783 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.99 - $2.9 $1,558 - $2,270	783 New	783 $2,000
Q4 2020 Feb 16, 2021	SELL	$1.88 - $2.84 $2,475 - $3,740	-1,317 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.69 - $4.95 $6,028 - $11,092	-2,241 Reduced 62.98%	1,317 $4,000
Q2 2020 Aug 13, 2020	BUY	$0.7 - $4.16 $2,490 - $14,801	3,558 New	3,558 $14,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.